Dominick Conde analyzes the Supreme Court’s January 20th, 2015 decision in Teva Pharmaceuticals v. Sandoz, which overturned the Federal Circuit’s de novo standard of review for district court claim constructions, and its implications on future patent litigations.
March 2015 | Intellectual Property Today
Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.: Where Does Claim Construction Go From Here?
1 min
Related Services
Related Insights
Sheeran Ruling Raises Burden for Copyright Plaintiffs
Sheeran Ruling Raises Burden for Copyright Plaintiffs
June 17, 2022
1min
What ecobee’s U.S. Victories Tell Canadians About American Patent Law
What ecobee’s U.S. Victories Tell Canadians About American Patent Law
June 09, 2022
2min
Nike StockX Battle Heats Up
Nike StockX Battle Heats Up
May 17, 2022
3min
Recent News
IAM Patent 1000 Continues to Recognize Venable’s IP Practice and Attorneys Among the Leaders in California, the DC Metro Area, Illinois, and New York for 2022
IAM Patent 1000 Continues to Recognize Venable’s IP Practice and Attorneys Among the Leaders in California, the DC Metro Area, Illinois, and New York for 2022
July 06, 2022
2min
Northern California Edition of Super Lawyers Recognizes Four Venable Attorneys; Three Rising Stars
Northern California Edition of Super Lawyers Recognizes Four Venable Attorneys; Three Rising Stars
July 05, 2022
1min
Venable Honors Jeff Nover, Carolyn Vinson, and Gary Dunn with 2022 Benjamin R. Civiletti Pro Bono Lawyer of the Year Awards
Venable Honors Jeff Nover, Carolyn Vinson, and Gary Dunn with 2022 Benjamin R. Civiletti Pro Bono Lawyer of the Year Awards
July 01, 2022
4min